| SCHEDULE OF SEGMENT INFORMATION |
As
of December 31, 2025, the Company currently has the following reportable segments: Homology of Medicine and Food Series, Computing Power
Product Series, Maca Product Series and others.
SCHEDULE
OF SEGMENT INFORMATION
| | |
Homology of Medicine and Food | | |
Computing Power Product | | |
Maca Product | | |
Unallocated Headquarter | | |
| |
| | |
Business Line | | |
Others | | |
| |
| | |
Homology of Medicine and Food | | |
Computing Power Product | | |
Maca Product | | |
Unallocated Headquarter | | |
| |
| | |
Series | | |
Series | | |
Series | | |
Costs | | |
Total | |
| Revenues, net | |
$ | 1,426,832 | | |
$ | 2,360,373 | | |
$ | 11,981,591 | | |
$ | - | | |
$ | 15,768,796 | |
| Cost of revenue | |
| (1,408,815 | ) | |
| (2,290,396 | ) | |
| (11,982,169 | ) | |
| - | | |
| (15,681,380 | ) |
| Gross profit | |
| 18,017 | | |
| 69,977 | | |
| (578 | ) | |
| - | | |
| 87,416 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Operating expenses | |
| (155,181 | ) | |
| (33,049 | ) | |
| (270,238 | ) | |
| (1,621,521 | ) | |
| (2,079,989 | ) |
| Loss from operations | |
| (137,164 | ) | |
| 36,928 | | |
| (270,816 | ) | |
| (1,621,521 | ) | |
| (1,992,573 | ) |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Fair value variation | |
| - | | |
| - | | |
| - | | |
| (17,502,596 | ) | |
| (17,502,596 | ) |
| Other income | |
| 74,271 | | |
| 177 | | |
| 1,654 | | |
| - | | |
| 76,102 | |
| Other expense | |
| (7,107 | ) | |
| (9 | ) | |
| (90 | ) | |
| - | | |
| (7,206 | ) |
| Segment Loss | |
$ | (70,000 | ) | |
| 37,096 | | |
| (269,252 | ) | |
| (19,124,117 | ) | |
| (19,426,273 | ) |
|